PATHOMICS
LIVE

Serial Number

79176495

Owner

HVIVO SERVICES LIMITED

Attorney

Mainak H. Mehta

Filing Date

Jan 22, 2015

Add to watchlist:

No watchlists yet
View on USPTO

PATHOMICS Trademark

Serial Number: 79176495 • Registration: 4962140

PATHOMICS is a trademark filed by HVIVO SERVICES LIMITED on January 22, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

HVIVO SERVICES LIMITED (15 trademarks)

Queen Mary BioEnterprises Innovation Centre,

Entity Type: 99

Retroscreen Virology Limited (9 trademarks)

Queen Mary BioEnterprises

Entity Type: 99

Trademark Details

Filing Date

January 22, 2015

Registration Date

May 24, 2016

Published for Opposition

March 8, 2016

Goods & Services

[ Pharmaceutical and medical compositions for human and/or veterinary use, namely, for the treatment of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, metabolic disorders, anti-infectives, occular disorders, and for use in oncology; vaccines for human beings and/or animals; adjuvants for use with vaccines; biological laboratory preparations for medical and/or veterinary purposes, namely, for the treatment of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, metabolic disorders, anti-infectives, occular disorders, and for use in oncology; chemical preparations and reagents for medical, pharmaceutical and veterinary purposes, namely, for the treatment of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, metabolic disorders, anti-infectives, occular disorders, and for use in oncology; viruses for the treatment of humans and/or animals; diagnostic preparations for medical purposes; in-vitro diagnostic preparations for medical purposes; in-vivo diagnostic preparations for medical purposes ]

Investigation and research services relating to cost and business efficiency, all relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; systemization and compilation of medical information into computer databases; business statistical information all relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; registration services for diagnostic testing; product demonstration services in the field of diagnostic testing; computer database management services, namely, database management services that allow for information storage in the fields of diagnostic testing and results, database management of medical, hospital, insurance and billing records and information storage and retrieval services in the fields of diagnostic testing and preparations for the treatment, monitoring or diagnosis of disease; trade information services in the fields of medical, health, or clinical care; database management of diagnostic testing and results, database management of medical, hospital, insurance or billing records; collation and provision of business information for the purpose of providing referral services in the fields of medical, health or clinical care; collation and provision of business information in the fields of medicine and pharmacy; collation and provision of business information regarding medical and pharmaceutical testing procedures; collation and provision of business information regarding disease conditions and disease prevention; collation and provision of business information regarding medical, hospital, insurance or billing records

Medical research services; conducting clinical trials for others; medical research laboratory services; medical research laboratory services for the analysis of samples taken from patients; scientific analysis and research services; product development relating to pharmaceuticals, medicines, medicaments and veterinary products; medical and health care research services, namely, clinical testing services, physician testing services for assisting pharmacists, pharmacy testing services, medical laboratory and testing services; medical research into the causes and treatment of influenza and the common cold

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
May 24, 2025 REM4
INTERNATIONAL REGISTRATION RENEWED
Sep 12, 2024 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Sep 16, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 8, 2023 INPS
INVALIDATION PROCESSED
Aug 8, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 7, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Nov 7, 2022 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Nov 7, 2022 71.P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Oct 31, 2022 EROP
POST REGISTRATION ACTION MAILED - SEC.71
May 24, 2022 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 23, 2022 APRE
TEAS SECTION 71 RECEIVED
Nov 11, 2021 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 24, 2021 REM3
NEW REPRESENTATIVE AT IB RECEIVED
May 9, 2019 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 24, 2016 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 16, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 25, 2016 FICS
FINAL DISPOSITION PROCESSED
Aug 25, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 24, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
May 24, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 8, 2016 NPUB
PUBLISHED FOR OPPOSITION
Mar 8, 2016 PUBO
NOTIFICATION PROCESSED BY IB
Mar 4, 2016 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 17, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 17, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 17, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 1, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 26, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2016 CRFA
ASSIGNED TO LIE
Jan 25, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2016 TROA
REFUSAL PROCESSED BY IB
Dec 31, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 4, 2015 RFCS
REFUSAL PROCESSED BY MPU
Dec 4, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 2, 2015 RFCR
NON-FINAL ACTION WRITTEN
Dec 1, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 25, 2015 MAFR
ASSIGNED TO EXAMINER
Nov 21, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 19, 2015 REPR